Related references
Note: Only part of the references are listed.The NLRP3 Inflammasome Renders Cell Death Pro-inflammatory
Moritz M. Gaidt et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
Agampodi Promoda Perera et al.
SCIENTIFIC REPORTS (2018)
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease
Mattia Cocco et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
C. Pellegrini et al.
NEUROPHARMACOLOGY (2017)
Inflammatory Bowel Disease and the NLRP3 Inflammasome
Thirumala-Devi Kanneganti
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inflammatory bowel disease following anti-interleukin-1-treatment in systemic juvenile idiopathic arthritis
Boris Huegle et al.
PEDIATRIC RHEUMATOLOGY (2017)
Canonical and Non-Canonical Activation of NLRP3 inflammasome at the Crossroad between immune Tolerance and intestinal inflammation
Carolina Pellegrini et al.
FRONTIERS IN IMMUNOLOGY (2017)
NLRP3 Inhibitors as Potential Therapeutic Agents for Treatment of Inflammatory Bowel Disease
Agampodi Promoda Perera et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Targeting the interleukin-1 pathway in patients with hematological disorders
Charlotte E. M. de Mooij et al.
BLOOD (2017)
Inflammasome-dependent IL-1β release depends upon membrane permeabilisation
F. Martin-Sanchez et al.
CELL DEATH AND DIFFERENTIATION (2016)
NLRP3 regulates a non-canonical platform for caspase-8 activation during epithelial cell apoptosis
H. Chung et al.
CELL DEATH AND DIFFERENTIATION (2016)
Design, Synthesis, and Evaluation of Acrylamide Derivatives as Direct NLRP3 Inflammasome Inhibitors
Mattia Cocco et al.
CHEMMEDCHEM (2016)
Apigenin supplementation protects the development of dextran sulfate sodium induced murine experimental colitis by inhibiting canonical and non-canonical inflammasome signaling pathways
Yazmin K. Marquez-Flores et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic
Matteo Fornai et al.
PHARMACOLOGICAL RESEARCH (2016)
Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD
Donata Lissner et al.
INFLAMMATORY BOWEL DISEASES (2015)
Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling
Christina Antonopoulos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Fumigaclavine C ameliorates dextran sulfate sodium-induced murine experimental colitis via NLRP3 inflammasome inhibition
Wenjie Guo et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Mechanism of NLRP3 inflammasome activation
Fayyaz S. Sutterwala et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
Susana Vallejo et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Postoperative Ileus Involves Interleukin-1 Receptor Signaling in Enteric Glia
Burkhard Stoffels et al.
GASTROENTEROLOGY (2014)
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis
Mattia Cocco et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Inflammasome activation has an important role in the development of spontaneous colitis
J. Zhang et al.
MUCOSAL IMMUNOLOGY (2014)
Animal models of inflammatory bowel disease: a review
Nidhi Goyal et al.
INFLAMMOPHARMACOLOGY (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome
Wen Liu et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure
Thomas Maslanik et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Caspase-11: The driving factor for noncanonical inflammasomes
Elena Vigano et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Second-Generation Corticosteroids for the Treatment of Crohn's Disease and Ulcerative Colitis: More Effective and Less Side Effects?
Chiara De Cassan et al.
DIGESTIVE DISEASES (2012)
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells
Margherita Coccia et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome
Sonja I. Gringhuis et al.
NATURE IMMUNOLOGY (2012)
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A. Dinarello et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Inflammatory bowel disease therapy: current state-of-the-art
Wojciech Blonski et al.
CURRENT OPINION IN GASTROENTEROLOGY (2011)
Non-canonical inflammasome activation targets caspase-11
Nobuhiko Kayagaki et al.
NATURE (2011)
MEDICAL PROGRESS Ulcerative Colitis
Silvio Danese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome
Christian Bauer et al.
GUT (2010)
The Blockade of Adenosine Deaminase Ameliorates Chronic Experimental Colitis through the Recruitment of Adenosine A2A and A3 Receptors
Luca Antonioli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
PPAR-alpha Contributes to the Anti-Inflammatory Activity of Verbascoside in a Model of Inflammatory Bowel Disease in Mice
Emanuela Esposito et al.
PPAR RESEARCH (2010)
Profile of soluble cytokine receptors in Crohn's disease
T Gustot et al.
GUT (2005)
Crohn disease worsened by anakinra administration
JD Carter et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2003)
Share Paper
